These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6494244)

  • 1. Drug safety in psychiatry--an objective for drug monitoring in phase IV.
    Schmidt LG; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1984 Sep; 17(5):152-6. PubMed ID: 6494244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A psychopharmacology education program for psychiatry residents--the role of a clinical pharmacist.
    Dorevitch A
    Isr J Psychiatry Relat Sci; 1994; 31(4):287-91. PubMed ID: 7875953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.
    Greenhill LL; Vitiello B; Abikoff H; Levine J; March JS; Riddle MA; Capasso L; Cooper TB; Davies M; Fisher P; Findling RL; Fried J; Labellarte MJ; McCracken JT; McMahon D; Robinson J; Skrobala A; Scahill L; Varipatis E; Walkup JT; Zito JM
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):651-5. PubMed ID: 12921472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AMSP drug safety program: methods and global results.
    Grohmann R; Engel RR; Rüther E; Hippius H
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S4-11. PubMed ID: 15052509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addiction training scale: pilot study of a self-report evaluation tool for psychiatry residents.
    Sattar SP; Madison J; Markert RJ; Bhatia SC; Petty F
    Acad Psychiatry; 2004; 28(3):204-8. PubMed ID: 15507555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
    Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of clinical psychiatry in the development of new drugs].
    Benkert O; Hippius H
    Arzneimittelforschung; 1975 Jul; 25(7a):1195-206. PubMed ID: 1242348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in adverse drug reactions in phase III and phase IV of the drug evaluation process.
    Linden M
    Psychopharmacol Bull; 1993; 29(1):51-6. PubMed ID: 8378512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AMDP-system in clinical psychopharmacology.
    Bobon D; Ansseau M
    Pharmacopsychiatry; 1986 Mar; 19(2):55-7. PubMed ID: 3703923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The private practice study group as phase-IV research tool.
    Helmchen H; Linden M; Schüssler G
    Pharmacopsychiatry; 1984 Sep; 17(5):157-61. PubMed ID: 6494245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical decision-making by psychiatry residents.
    El-Mallakh R; Zinner J; Mackey A; Tamas RL; Martin CM; Dalton J; Dhaliwal N; Luddington N; Numan FU; Nunes R; Taylor S; Ye L
    Acad Psychiatry; 2007; 31(4):326-8. PubMed ID: 17626195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems in the current psychiatry residency training program in Croatia: residents' perspective.
    Kuzman MR; Jovanović N; Vidović D; Margetić BA; Mayer N; Zelić SB; Lasić D; Nadj S; Simurina AB; Slijepcević MK; Bolanca M; Skocić M; Katić P; Soskić T; Plestina S
    Coll Antropol; 2009 Mar; 33(1):217-23. PubMed ID: 19408629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of safety assessment methods used in pediatric psychopharmacology.
    Greenhill LL; Vitiello B; Riddle MA; Fisher P; Shockey E; March JS; Levine J; Fried J; Abikoff H; Zito JM; McCracken JT; Findling RL; Robinson J; Cooper TB; Davies M; Varipatis E; Labellarte MJ; Scahill L; Walkup JT; Capasso L; Rosengarten J
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):627-33. PubMed ID: 12921469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of medical toxicology training in psychiatry residency programs.
    Ingels M; Marks D; Clark RF
    Acad Psychiatry; 2003; 27(1):50-3. PubMed ID: 12824122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A few words on the quantification of clinical data in psychiatric research].
    Luccioni H
    Acta Psychiatr Belg; 1983; 83(2):163-8. PubMed ID: 6353869
    [No Abstract]   [Full Text] [Related]  

  • 16. Does psychiatry residency training reflect the "real world" of psychiatry practice? A survey of residency graduates.
    Petersen T; Fava M; Alpert JE; Vorono S; Sanders KM; Mischoulon D
    Acad Psychiatry; 2007; 31(4):281-9. PubMed ID: 17626190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacology training in psychiatric residency programs: the Canadian scene.
    Awad AG; Darby PL; Garfinkel PE
    Can J Psychiatry; 1991 Feb; 36(1):21-5. PubMed ID: 2029679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does evidence from clinical trials in psychopharmacology apply in clinical practice?
    Stahl SM
    J Clin Psychiatry; 2001 Jan; 62(1):6-7. PubMed ID: 11235934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of psychopharmacology on the American Board of Psychiatry and Neurology examinations.
    Juul D; Winstead DK; Sheiber SC
    Acad Psychiatry; 2005; 29(2):211-4. PubMed ID: 15937269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac adverse effects associated with psychotropic drugs.
    Schmid C; Grohmann R; Engel RR; Rüther E; Kropp S
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S65-9. PubMed ID: 15052516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.